Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 1/2 1

Status

Completed 4Recruiting 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 2Tumor-Agnostic 1Genitourinary 1

Conditions

Lung Neoplasms 2Prostatic Neoplasms 1Neoplasms 1

Interventions

pembrolizumab 245Nivolumab 141Cisplatin 137Cyclophosphamide 134Paclitaxel 115Carboplatin 108Gemcitabine 98Radiotherapy 84Dexamethasone 83Docetaxel 77atezolizumab 69Ipilimumab 67Fluorouracil 61Doxorubicin 61Blood Specimen Collection 59Bevacizumab 59Rituximab 55fludarabine 54Etoposide 53Oxaliplatin 52Lenalidomide 50Surveys and Questionnaires 49Prednisone 47Standard of Care 45Magnetic Resonance Spectroscopy 45Radiosurgery 44Cetuximab 44lenvatinib 43Capecitabine 43durvalumab 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Patient Education as Topic × 1 year × Clear all
NCT06225414 2026-03-30

Empowering Hispanic Patients' Lung Cancer Screening Uptake (Empower Latinx)

University of California, Irvine

Phase NA Completed
60 enrolled
Thoracic

Lung Neoplasms

NCT04705038 2026-03-27

Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments

University of Chicago

Phase NA Completed
101 enrolled
Genitourinary

Prostatic Neoplasms

NCT05046171 2026-03-24

Decreasing Polypharmacy in Older Adults With Curable Cancers Trial

University of Rochester

Phase 1/2 Completed
51 enrolled
Tumor-Agnostic

Neoplasms

NCT06000683 2026-02-20

Empower-LCS

University of California, Irvine

Phase NA Completed
79 enrolled 20 charts
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡